Early-stage medtech developer Techsomed said yesterday that it raised $2.6 million to support its BioTrace image analysis platform designed to predict post-treatment ablation morphology in real time in a round led by Johnson & Johnson (NYSE:JNJ) Innovation. Funds from the offering will be used to support FDA, PMDA and CE Mark approval in the European Union, […]